Future perspectives in diabesity treatment: Semaglutide, a glucagon-like peptide 1 receptor agonist (Review)

Given their endemic prevalence in the past decades, obesity and type 2 diabetes mellitus (T2DM) have become a major sanitary burden with an important economic impact. Novel treatment options have been designed with the aim of reducing the numerous complications associated with these metabolic disord...

Descripción completa

Detalles Bibliográficos
Autores principales: Tilinca, Mariana Cornelia, Tiuca, Robert Aurelian, Niculas, Cristina, Varga, Andreea, Tilea, Ioan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394024/
https://www.ncbi.nlm.nih.gov/pubmed/34504612
http://dx.doi.org/10.3892/etm.2021.10601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394024/
https://www.ncbi.nlm.nih.gov/pubmed/34504612
http://dx.doi.org/10.3892/etm.2021.10601

Ejemplares similares